Flux rss du site Inserm Transfert http://licensing.inserm.fr Voici notre flux rss en cours New biodegradable microspheres formulated in pressurized CO2 Application to the encapsulation and controlled release of active compoundshttp://licensing.inserm.fr/fiche.php?artid=30Tue, 16 Dec 2008 15:54:52 GMT Propionyl-coA precursors for the treatment of poly-glutamine diseases Anaplerotic Krebs cycle stimulators as therapeutic targetshttp://licensing.inserm.fr/fiche.php?artid=31Thu, 14 Jan 2010 15:07:37 GMT Novel Human HER-2/neu antibody fragment A promising cancer vaccine candidatehttp://licensing.inserm.fr/fiche.php?artid=32Tue, 16 Dec 2008 15:54:43 GMT Bioactive coatings made of polyelectrolyte multilayers http://licensing.inserm.fr/fiche.php?artid=24Tue, 03 Mar 2009 10:48:13 GMT A new generation of polyelectrolyte multilayer film's system http://licensing.inserm.fr/fiche.php?artid=26Mon, 15 Dec 2008 14:32:18 GMT A new kit for pronostic and therapeutic of colorectal cancers Better patient classification for high-risk of relapse than TMN histologicalhttp://licensing.inserm.fr/fiche.php?artid=27Thu, 06 Nov 2008 11:11:18 GMT ThyX, a novel thymydilate synthase and related inhibitors http://licensing.inserm.fr/fiche.php?artid=33Wed, 06 Jan 2010 15:39:44 GMT Use of novel flagellin- derived peptides as mucosal adjuvant http://licensing.inserm.fr/fiche.php?artid=146Wed, 06 Jan 2010 15:40:33 GMT Polymorphisms in the EPCR gene and thrombotic risk http://licensing.inserm.fr/fiche.php?artid=35Thu, 14 Jan 2010 15:09:23 GMT A novel marker of sensitivity or resistance to anti-tumoral treatment Theranostic kit for chemotherapyhttp://licensing.inserm.fr/fiche.php?artid=36Tue, 04 Nov 2008 15:35:41 GMT Broad applications of a crosslinked polyelectrolyte multilayer film http://licensing.inserm.fr/fiche.php?artid=37Tue, 03 Mar 2009 10:51:58 GMT Anti-Restenosis by MRP4 gene inhibition http://licensing.inserm.fr/fiche.php?artid=38Thu, 14 Jan 2010 15:09:09 GMT Spatiotemporal cartography Software by multiple-target tracing method probe High Throughput screening software for multiple targetshttp://licensing.inserm.fr/fiche.php?artid=106Wed, 03 Mar 2010 11:34:32 GMT Method for quantifyingVEGF121/VEGF 165 isoforms in a biological sample Prognosis of survival in solid cancer and AMLhttp://licensing.inserm.fr/fiche.php?artid=105Mon, 15 Dec 2008 17:20:18 GMT A method for predicting the responsiveness to anti-TNFa antibody treatment IL15 and sIL15Ra implicated in the response to treatment in Crohn's diseasehttp://licensing.inserm.fr/fiche.php?artid=158Fri, 31 Jul 2009 09:12:46 GMT An in-vitro method for expanding monocytes http://licensing.inserm.fr/fiche.php?artid=40Wed, 03 Mar 2010 11:32:49 GMT Artemis,a gene implied in DNA reparation and VDJ recombination http://licensing.inserm.fr/fiche.php?artid=43Wed, 02 Dec 2009 09:30:08 GMT the NPHS2 gene implicated in steroid-resistant nephrotic syndrome http://licensing.inserm.fr/fiche.php?artid=47Tue, 04 Nov 2008 15:57:36 GMT human Skin substitutes from Human Pluripotent Stem Cell 1st truly established skin substitutes worldwidehttp://licensing.inserm.fr/fiche.php?artid=94Tue, 09 Dec 2008 15:01:44 GMT A new treatment for glomerulonephritis http://licensing.inserm.fr/fiche.php?artid=51Tue, 04 Nov 2008 16:03:15 GMT Prediction of the responsiveness to a treatment for Multiple sclerosis http://licensing.inserm.fr/fiche.php?artid=52Thu, 14 Jan 2010 15:08:58 GMT Fluorescent Nano diamonds and its method of production Use as a labeling marker/tool for research, in-vitro diagnostichttp://licensing.inserm.fr/fiche.php?artid=78Thu, 11 Dec 2008 16:18:13 GMT Methods for the treatment,the prognostic and the detection of breast cancer Early diagnosis-differentiate at stage 0 between calcification and tumorhttp://licensing.inserm.fr/fiche.php?artid=131Mon, 23 Mar 2009 17:22:14 GMT A strategy to generate new compound conformations with enhanced efficacy The concept : sublimation under vaccum followed by solid deposition http://licensing.inserm.fr/fiche.php?artid=92Thu, 11 Dec 2008 16:08:31 GMT CD31-derived fragment for the treatment of atherosclerosis A new therapeutic window through immunoregulationhttp://licensing.inserm.fr/fiche.php?artid=101Thu, 14 Jan 2010 15:07:54 GMT CNF1 and related Rho GTPases activators as adjuvant for mucosal vaccination http://licensing.inserm.fr/fiche.php?artid=86Wed, 03 Mar 2010 11:22:10 GMT Identification of genetic markers associated to cancer of pancreas CNV-based biomarker in sporadic pancreatic cancerhttp://licensing.inserm.fr/fiche.php?artid=54Mon, 15 Dec 2008 15:22:08 GMT New polypeptides in cancer therapy http://licensing.inserm.fr/fiche.php?artid=55Mon, 27 Jul 2009 08:55:31 GMT Novel antibacterials for treating latent tuberculosis Novel original target from dormant tuberculosis bacillus (TB)http://licensing.inserm.fr/fiche.php?artid=56Wed, 03 Mar 2010 11:32:14 GMT The role of a phosphotase PTPL1 as survival prognostic in breast cancer http://licensing.inserm.fr/fiche.php?artid=58Wed, 25 Nov 2009 08:52:21 GMT Novel imaging agents for fibrosis (lung, heart, liver) http://licensing.inserm.fr/fiche.php?artid=59Tue, 18 Nov 2008 19:40:46 GMT Prognostic of breast cancer development into local metastasis (bone, lung) http://licensing.inserm.fr/fiche.php?artid=60Tue, 18 Nov 2008 19:38:40 GMT Inhibitor of STIM1 for the treatment of cardiovascular disorders http://licensing.inserm.fr/fiche.php?artid=70Thu, 14 Jan 2010 15:08:21 GMT Antagonists and agonists mutants of humans IL-15 Control of the IL-15 affinity for its receptor IL-15α http://licensing.inserm.fr/fiche.php?artid=62Tue, 16 Dec 2008 15:55:00 GMT Interleukin-15 receptor: a biomarker of survival for head and neck cancers http://licensing.inserm.fr/fiche.php?artid=63Tue, 18 Nov 2008 19:35:19 GMT Microsensor of arterial pressure http://licensing.inserm.fr/fiche.php?artid=64Tue, 04 Nov 2008 16:07:23 GMT Method for predicting therapeutics responsiveness to TNF-a blocking agents Inflammation and Biomarker in Rheumatoid Arthritis (RA)http://licensing.inserm.fr/fiche.php?artid=156Fri, 31 Jul 2009 09:14:51 GMT Methods of classification and prognosis of hepatocellular carcinoma http://licensing.inserm.fr/fiche.php?artid=66Fri, 31 Jul 2009 09:20:23 GMT Biomarker for liver lesions diagnosis of obese patients http://licensing.inserm.fr/fiche.php?artid=67Thu, 14 Jan 2010 15:08:10 GMT Early diagnosis of prostate cancer using a protein receptor Imaging, In vitro diagnostic, radiotherapy and immunotherapyhttp://licensing.inserm.fr/fiche.php?artid=68Tue, 03 Mar 2009 10:38:34 GMT Methods for the prognosis or for the diagnosis of a thyroid disease http://licensing.inserm.fr/fiche.php?artid=69Tue, 04 Nov 2008 15:54:12 GMT A gene-based classifier for prognosis in multiple myeloma Prognosis of disease outcome for treatment selectionhttp://licensing.inserm.fr/fiche.php?artid=93Fri, 05 Dec 2008 16:17:06 GMT Highly Sensitive Prion Detection Technology http://licensing.inserm.fr/fiche.php?artid=74Wed, 03 Mar 2010 11:31:49 GMT Use of HB-19 pseudo-peptide to inhibit infection by Francisella tularensis http://licensing.inserm.fr/fiche.php?artid=83Wed, 03 Mar 2010 11:31:27 GMT Novel diagnostic agent of the liver function reserve (LFR) Radiopharmaceuticals with simplified preparationhttp://licensing.inserm.fr/fiche.php?artid=76Thu, 11 Dec 2008 16:51:36 GMT Fusion proteins for optimal antigen presentation in vaccine strategy http://licensing.inserm.fr/fiche.php?artid=84Wed, 03 Mar 2010 11:30:57 GMT A novel therapeutic vaccine approach for resistant pathogens http://licensing.inserm.fr/fiche.php?artid=85Wed, 03 Mar 2010 11:30:25 GMT Uridine derivatives as antivirals against a flaviviridae, especially HCV http://licensing.inserm.fr/fiche.php?artid=87Wed, 06 Jan 2010 15:41:34 GMT Prognosis and diagnosis of agressiveness of non small cell lung cancer Based on a protein and its corresponding receptorhttp://licensing.inserm.fr/fiche.php?artid=88Mon, 05 Jan 2009 15:40:36 GMT New Gossypol derivatives promotes apoptosis in cancer cells http://licensing.inserm.fr/fiche.php?artid=89Fri, 12 Dec 2008 16:16:27 GMT Chirp reversal ultrasound contrast imaging Ultra-Sound imaging. myocardial perfusion detectionhttp://licensing.inserm.fr/fiche.php?artid=95Thu, 11 Dec 2008 17:04:03 GMT Compensation of nonlinear behavior of capacitive micromachined transducers Ultra-Sound imaging. Enhancement of existing CMUT-based equipmenthttp://licensing.inserm.fr/fiche.php?artid=96Thu, 11 Dec 2008 17:15:21 GMT Development of new molecules with antiproloferative activities Thiazolopyrimidine derivativeshttp://licensing.inserm.fr/fiche.php?artid=97Tue, 03 Mar 2009 10:15:08 GMT Triazole nucleoside derivatives for cancer therapy http://licensing.inserm.fr/fiche.php?artid=99Tue, 16 Dec 2008 15:55:09 GMT BENA 435, a new cell-permeant green fluorescent DNA probe http://licensing.inserm.fr/fiche.php?artid=102Mon, 15 Dec 2008 09:48:57 GMT Measles nucleoprotein fragments and atherosclerosis http://licensing.inserm.fr/fiche.php?artid=103Mon, 15 Dec 2008 11:48:41 GMT Use of an EGFR antagonist for the treatment of Glomerulonephritis Method for Therapeutic treatmenthttp://licensing.inserm.fr/fiche.php?artid=107Fri, 23 Jan 2009 10:43:58 GMT Aminoisobutyric acid (BAIBA) prevents diet-induced obesity Method for the treatment of diseases linked to the accumulation of triglycerideshttp://licensing.inserm.fr/fiche.php?artid=108Wed, 02 Dec 2009 09:31:13 GMT A new transgenic model for rheumatoid polyarthritis (mouse and serum) A new transgenic model for rheumatoid polyarthritis (mouse and serum)http://licensing.inserm.fr/fiche.php?artid=109Wed, 02 Dec 2009 09:32:15 GMT A specific marker of synovium degradation http://licensing.inserm.fr/fiche.php?artid=110Fri, 31 Jul 2009 09:19:12 GMT Obtaining of NGN3-expressing cells and insulin producing-beta cells Method for obtaining NGN3-expressing cells and insulin producing-beta cellshttp://licensing.inserm.fr/fiche.php?artid=125Mon, 03 Aug 2009 09:53:50 GMT Methods and kits for the diagnosis of Rheumatoid Arthritis http://licensing.inserm.fr/fiche.php?artid=112Fri, 31 Jul 2009 09:17:13 GMT Use of agonists of integrin alpha 5 for bone repair and regeneration http://licensing.inserm.fr/fiche.php?artid=124Mon, 14 Dec 2009 14:31:52 GMT HIGH PURITY CULTURES OF MAMALIAN AND HUMAN CONE PHOTORECEPTOR CELLS First method to obtain 80-92% pure population of coneshttp://licensing.inserm.fr/fiche.php?artid=113Wed, 25 Nov 2009 08:49:00 GMT New target for angiogenisis modulation Ubiquitous protein, multiple applicationshttp://licensing.inserm.fr/fiche.php?artid=115Wed, 25 Nov 2009 08:49:59 GMT Vector for mitochondrial gene targeting Optimized mitochondrial gene targeting and expressionhttp://licensing.inserm.fr/fiche.php?artid=116Thu, 19 Feb 2009 09:25:07 GMT 3D Porous hydrogels These hydrogels can be loaded with cells or active ingredients for :http://licensing.inserm.fr/fiche.php?artid=117Tue, 03 Mar 2009 11:11:17 GMT 3 D Porous hydrogels providing a scaffold with lamellar pores These hydrogels can be used loaded with cells or active ingredients for :http://licensing.inserm.fr/fiche.php?artid=118Wed, 03 Mar 2010 11:34:55 GMT Microsatellite markers for the detection of MSI http://licensing.inserm.fr/fiche.php?artid=120Wed, 02 Dec 2009 09:33:02 GMT Polarized morphologic chamber http://licensing.inserm.fr/fiche.php?artid=121Wed, 02 Dec 2009 09:34:39 GMT Soluble HLA-E molecules for diagnosing and treating pathology Production of soluble HLA-E by activated endothelial cells and melanoma cells http://licensing.inserm.fr/fiche.php?artid=122Wed, 02 Dec 2009 09:33:42 GMT Peptidic antagonist of Neuropilin-1 http://licensing.inserm.fr/fiche.php?artid=123Fri, 07 Aug 2009 15:08:34 GMT Phosphoproteins as additional KRAS biomarkers of response to anti-EGFR Biomarker of response to treatment (anti-EGFR), completing & independent of http://licensing.inserm.fr/fiche.php?artid=127Wed, 25 Nov 2009 08:44:20 GMT Differentiation-inducing agents as therapy in Acute Myeloid Leukemia Targeting of iron homeostasis induces cell differentiation -synergetic effecthttp://licensing.inserm.fr/fiche.php?artid=128Wed, 25 Nov 2009 08:44:03 GMT Constitutively active mutants of the prolactin receptor http://licensing.inserm.fr/fiche.php?artid=129Fri, 13 Mar 2009 09:38:18 GMT Methods for the treatment, the prognostic assessment of mesothelioma Neurotensin as a biomarker of prognosishttp://licensing.inserm.fr/fiche.php?artid=130Fri, 06 Mar 2009 16:35:46 GMT Galectin-1 (GAL1)as differential diagnosis of osteo & chondrosarcoma Treatment choice to be applied is different (surgery only for CS)http://licensing.inserm.fr/fiche.php?artid=132Wed, 25 Nov 2009 08:43:33 GMT Platelet production from megacaryocytes and hematopoietic stem cells http://licensing.inserm.fr/fiche.php?artid=133Wed, 06 Jan 2010 15:41:12 GMT Human specific avirulent Escherichia coli strain ED1a, B2 VIII/O81 http://licensing.inserm.fr/fiche.php?artid=135Mon, 01 Feb 2010 15:09:38 GMT 6D6, an inhibitor of PEA-15 with potential interest in diabetes and cancer http://licensing.inserm.fr/fiche.php?artid=136Thu, 23 Apr 2009 12:57:48 GMT Endo-prosthesis for cartilage lesions Based on regular titan stentshttp://licensing.inserm.fr/fiche.php?artid=139Mon, 23 Mar 2009 17:01:59 GMT New treatment for spinocerebellar ataxia and other polyglutamine diseases http://licensing.inserm.fr/fiche.php?artid=141Thu, 14 Jan 2010 15:08:47 GMT Ligand for selectin imaging Multi-modality: MRI, UltraSound, PET, Scintigraphy agenthttp://licensing.inserm.fr/fiche.php?artid=143Wed, 25 Nov 2009 08:48:01 GMT Treatment and diagnosis of bone mineral density related diseases http://licensing.inserm.fr/fiche.php?artid=154Thu, 30 Jul 2009 14:01:04 GMT Use of L-alpha-lysophasphatidylcholine (LPC) as adjuvant for vaccination Use of LPS for inducing DC maturation ex-vivohttp://licensing.inserm.fr/fiche.php?artid=145Wed, 06 Jan 2010 15:40:45 GMT Polymorphism and genetic susceptibility to thyroid dysgenesis Polymorphism of the FOXE1 gene and genetic susceptibility to thyroid dysgenesishttp://licensing.inserm.fr/fiche.php?artid=147Thu, 09 Apr 2009 15:30:07 GMT Non conventional NKT cells for use in cancer therapy http://licensing.inserm.fr/fiche.php?artid=150Wed, 06 Jan 2010 15:40:12 GMT Serological methods and Kits for the diagnosis of Rheumatoid Arthritis (RA) http://licensing.inserm.fr/fiche.php?artid=157Fri, 31 Jul 2009 09:14:01 GMT Innovative therapeutic tools for rheumatic diseases Method for chondrogenic differentiation of pluripotent or multipotent stem cellshttp://licensing.inserm.fr/fiche.php?artid=159Tue, 24 Nov 2009 10:52:28 GMT Genes responsible for spastic paraplegia 2 novel genes and targetshttp://licensing.inserm.fr/fiche.php?artid=167Thu, 14 Jan 2010 15:06:41 GMT A polypeptide for inhibiting or preventing neuronal apoptosis 12 AA to prevent neuronal apoptosishttp://licensing.inserm.fr/fiche.php?artid=163Thu, 14 Jan 2010 15:07:15 GMT Serotonine uptake inhibitors for the treatment of Rett syndrom Fluoxetin treatment in orphan pediatric diseasehttp://licensing.inserm.fr/fiche.php?artid=166Thu, 14 Jan 2010 15:08:31 GMT BOTOX-like peptide Inhibitor of synaptic transmissionhttp://licensing.inserm.fr/fiche.php?artid=168Thu, 14 Jan 2010 15:06:20 GMT sAPPα detection in Alzheimer disease HTRF test for screening compounds stimulating α-secretase pathway http://licensing.inserm.fr/fiche.php?artid=169Mon, 01 Mar 2010 08:53:59 GMT CXCL5 as a market of hormone escape in prostate cancer Predict hormone escape and resistance to hormono dependant therapyhttp://licensing.inserm.fr/fiche.php?artid=171Wed, 25 Nov 2009 08:47:12 GMT